全文获取类型
收费全文 | 5810篇 |
免费 | 245篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 150篇 |
妇产科学 | 61篇 |
基础医学 | 627篇 |
口腔科学 | 163篇 |
临床医学 | 371篇 |
内科学 | 1323篇 |
皮肤病学 | 62篇 |
神经病学 | 465篇 |
特种医学 | 275篇 |
外科学 | 975篇 |
综合类 | 19篇 |
预防医学 | 302篇 |
眼科学 | 75篇 |
药学 | 556篇 |
中国医学 | 9篇 |
肿瘤学 | 564篇 |
出版年
2023年 | 28篇 |
2022年 | 51篇 |
2021年 | 97篇 |
2020年 | 48篇 |
2019年 | 62篇 |
2018年 | 85篇 |
2017年 | 78篇 |
2016年 | 80篇 |
2015年 | 78篇 |
2014年 | 125篇 |
2013年 | 179篇 |
2012年 | 250篇 |
2011年 | 294篇 |
2010年 | 154篇 |
2009年 | 98篇 |
2008年 | 210篇 |
2007年 | 263篇 |
2006年 | 242篇 |
2005年 | 273篇 |
2004年 | 244篇 |
2003年 | 228篇 |
2002年 | 259篇 |
2001年 | 219篇 |
2000年 | 201篇 |
1999年 | 203篇 |
1998年 | 79篇 |
1997年 | 73篇 |
1996年 | 75篇 |
1995年 | 62篇 |
1994年 | 67篇 |
1993年 | 67篇 |
1992年 | 177篇 |
1991年 | 168篇 |
1990年 | 143篇 |
1989年 | 130篇 |
1988年 | 120篇 |
1987年 | 106篇 |
1986年 | 114篇 |
1985年 | 116篇 |
1984年 | 63篇 |
1983年 | 63篇 |
1982年 | 33篇 |
1981年 | 29篇 |
1980年 | 24篇 |
1979年 | 46篇 |
1978年 | 22篇 |
1975年 | 25篇 |
1974年 | 27篇 |
1971年 | 21篇 |
1969年 | 21篇 |
排序方式: 共有6072条查询结果,搜索用时 0 毫秒
81.
82.
Masahiro Toda Kanehisa Morimoto 《Scandinavian journal of clinical and laboratory investigation》2013,73(8):823-825
We measured salivary adiponectin levels in saliva samples collected in two different ways and compared the results. Using the Salivette system, we collected samples from 30 healthy females into test tubes. Salivary adiponectin levels were evaluated using a commercial enzyme immunoassay kit for plasma but with a slightly modified method. While there was a significant correlation between adiponectin levels in plasma and test‐tube saliva (p<0.05), no correlation between adiponectin levels in plasma and Salivette‐sampled saliva was apparent. These findings suggest that test‐tube sampling is more reliable than use of the Salivette system for measuring salivary adiponectin levels. 相似文献
83.
Kitaoka H Kuwahara T Nishida K Morimoto K Kubo T Okawa M Furuno T Doi Y 《Journal of cardiology》2005,45(4):155-159
A 41-year-old man was referred to our hospital for further examination because of abnormal electrocardiography findings at a health-check examination. Transthoracic echocardiography showed left ventricular hypertrophy confined to the most distal portion of the left ventricle, which is a typical feature of apical hypertrophic cardiomyopathy. Ten years later, he was again admitted for the evaluation of chest pain. Echocardiography showed asymmetrical septal hypertrophy in addition to apical hypertrophy. These findings demonstrate morphologic evolution in hypertrophic cardiomyopathy from apical hypertrophy to asymmetrical septal hypertrophy. 相似文献
84.
Effects of alendronate on bone mineral density and bone metabolic markers in postmenopausal asthmatic women treated with inhaled corticosteroids 总被引:1,自引:0,他引:1
Kasayama S Fujita M Goya K Yamamoto H Fujita K Morimoto Y Kawase I Miyatake A 《Metabolism: clinical and experimental》2005,54(1):85-90
We have recently shown that long-term use of inhaled corticosteroids decreases bone mineral density (BMD) of the lumbar spine in postmenopausal asthmatic women. The present study aimed to evaluate the efficacy of alendronate in comparison with that of alfacalcidol (1-alpha-hydroxyvitamin D(3)) for the treatment of BMD reduction in postmenopausal asthmatic patients who had inhaled corticosteroid therapy without regular use of systemic corticosteroids. Twenty-eight postmenopausal asthmatic patients with BMD T score of -1.0 or less were randomized to receive alendronate (5 mg/d) or alfacalcidol (1 microg/d). Bone mineral density was determined at baseline and 12 months after the treatment, and biochemical markers of bone metabolism were measured at baseline and after 6 and 12 months of treatment. The mean (+/-SD) BMD values at the lumbar spine, the total hip, and the Ward's triangle significantly increased by 4.9 +/- 4.5% (P = .0005), 2.4 +/- 2.2% (P = .0005), and 3.6 +/- 5.2% (P = .02) at 12 months in the alendronate group, whereas the corresponding values did not significantly change in the alfacalcidol group. In the alendronate group, urinary N-telopeptide (NTx), serum osteocalcin, and serum alkaline phosphatase concentrations significantly decreased, and serum intact parathyroid (PTH) level significantly increased, from baseline at both 6 and 12 months. In the alfacalcidol group, urinary NTx showed modest but significant decrease, although the extent of the change was smaller than that in the alendronate group. We concluded that alendronate was effective to improve reduced BMD in postmenopausal asthmatic patients on inhaled corticosteroid therapy through the mechanism of inhibiting bone resorption. 相似文献
85.
T Tono T Tsujimura U Koshimizu T Kasugai S Adachi K Isozaki S Nishikawa M Morimoto Y Nishimune S Nomura 《Blood》1992,80(6):1448-1453
86.
Arata Tabuchi Ryoji Taniguchi Kanako Takahashi Hirokazu Kondo Mitsunori Kawato Takeshi Morimoto Takeshi Kimura Toru Kita Hisanori Horiuchi 《Circulation journal》2008,72(3):420-426
BACKGROUND: There are few monitoring systems widely used in clinical practice for evaluating the effectiveness of aspirin therapy, so in the present study aspirin's antiplatelet effects we investigated with a whole blood aggregometer using a screen filtration pressure (SFP) method. METHODS AND RESULTS: Thirty-five healthy male volunteers took 100 mg/day aspirin for 14 days. Whole-blood aggregation was analyzed at baseline and on days 7 and 14, using collagen and adenosine diphosphate as the stimuli, and compared with the platelet-rich plasma (PRP) aggregation measured by optical aggregometer. The platelet-aggregation threshold index (PATI) for both methods, which was defined as the putative agonist-concentration giving half-maximal aggregation, and the PRP-maximal aggregation rate were analyzed. The maximal aggregation rate induced by 1.6 mg/L collagen decreased from 85.5% (80.8-92.8) [median (interquartile range)] at baseline to 51.5% (39-63.8) on day 14 (p<0.0001). The PRP-PATI and whole-blood PATI for collagen increased from 0.32 (0.28-0.70) to 1.82 mg/L (1.25-2.89) (p<0.0001) and from 0.28 (0.22-0.3) to 1.06 mg/L (1.01-1.29) (p<0.0001) respectively. CONCLUSIONS: The whole-blood PATI and PRP-PATI for collagen, as well as the maximal PRP aggregation rate, clearly distinguish platelet aggregability before and after aspirin intake. However, whole-blood analysis by the SFP-method is easier to perform, and is a promising method of monitoring aspirin's effects. 相似文献
87.
Kuriyama M Kato J Kuwaki K Morimoto N Nawa T Fujimoto T Kono H Okano N Miyaike J Morita T Okada H Suzuki S Yoshioka T Shiode J Suwaki K Sakaguchi K Shiratori Y;Japan West Ulcerative Colitis Study Group 《European journal of gastroenterology & hepatology》2008,20(7):634-641
BACKGROUND AND AIM: The health-related quality of life (HRQOL) of patients with ulcerative colitis (UC) can be impaired because of the chronic symptoms. Although UC patients suffer from such symptoms over the long term, there have been few reports on the changes of HRQOL with disease duration. The aim of this study was to clarify these changes. METHODS: The HRQOL of 331 Japanese UC patients was examined using the validated Japanese version of the Inflammatory Bowel Disease Questionnaire (J-IBDQ). HRQOL and factors affecting HRQOL identified using multiple linear regression analysis were stratified by disease duration. RESULTS: Of the 15 clinical factors examined, the clinical activity index score was the strongest determinant (P<0.0001) of all the scores of IBDQ regardless of disease duration. HRQOL did not differ significantly among patients with different disease durations. The factors, however, that affected HRQOL varied according to disease duration. In patients with disease duration of less than 5 years, the clinical activity index score was the predominant factor affecting HRQOL. Being 'on sick leave or hospitalized' was a significant factor impairing HRQOL in patients with disease duration of 5-9 years. Moreover, complications due to corticosteroids significantly impaired all of the IBDQ scores in patients with disease duration of 10 years or more. CONCLUSION: Factors that affected the HRQOL of UC patients varied according to the patients' disease duration. Our findings should assist in the development of a long-term strategy for the treatment of UC patients. 相似文献
88.
Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux 总被引:2,自引:0,他引:2
Mine S Fujisaki T Tabata T Matsuoka H Iida T Yamada S Tanaka Y Morimoto I Eto S Aibe T 《The American journal of gastroenterology》2000,95(2):381-386
OBJECTIVE: Endoscopic ultrasonographic (EUS) changes in gastroesophageal reflux disease (GERD) after treatment with proton pump inhibitor have been poorly evaluated. We conducted a randomized, double-blind 12-wk clinical trial to compare the EUS effects of lansoprazole to histamine H2-receptor antagonist therapy in GERD. METHODS: Seventeen patients with reflux-related symptoms received 40 mg of famotidine for 6 wk or 30 mg of lansoprazole for 6 wk followed by 40 mg of famotidine or 30 mg of lansoprazole for another 6 wk, respectively. Patients underwent EUS before and at 6 and 12 wk after treatment. RESULTS: Before treatment, a variable degree of wall thickening was noted on EUS in the lower esophagus, compared with 20 normal subjects. After 6 wk of therapy, esophageal wall was significantly thicker in the famotidine group compared with the lansoprazole group (p<0.01). Surprisingly, thickening of esophageal wall and abnormal architecture were also detected in endoscopically negative reflux disease. Lansoprazole was superior to famotidine in reducing the thickness of esophageal wall. CONCLUSIONS: EUS was very useful for evaluation of submucosal injury in patients with GERD. EUS showed that a 6-wk course of lansoprazole therapy reduced thickening of esophageal wall, which was resistant to histamine H2-receptor antagonist therapy. Our results also suggest that inflammatory damage to the submucosal and muscle layers of the lower esophagus is the underlying mechanism of heartburn and associated symptoms in patients with endoscopically negative reflux disease. 相似文献
89.
Yushiro Endo Shin-ya Kawashiri Shimpei Morimoto Ayako Nishino Momoko Okamoto Sosuke Tsuji Ayuko Takatani Toshimasa Shimizu Remi Sumiyoshi Takashi Igawa Tomohiro Koga Naoki Iwamoto Kunihiro Ichinose Mami Tamai Hideki Nakamura Tomoki Origuchi Yukitaka Ueki Tamami Yoshitama Nobutaka Eiraku Naoki Matsuoka Akitomo Okada Keita Fujikawa Hideo Otsubo Hirokazu Takaoka Hiroaki Hamada Tomomi Tsuru Shuji Nagano Arinobu Yojiro Toshihiko Hidaka Yoshifumi Tada Atsushi Kawakami 《Medicine》2021,100(1)
We aimed to evaluate the utility of a simplified ultrasonography (US) scoring system, which is desired in daily clinical practice, among patients with rheumatoid arthritis (RA) receiving biological/targeted synthetic disease-modifying antirheumatic drugs (DMARDs).A total of 289 Japanese patients with RA who were started on tumor necrosis factor inhibitors, abatacept, tocilizumab, or Janus kinase inhibitors between June 2013 and April 2019 at one of the 15 participating rheumatology centers were reviewed. We performed US assessment of articular synovia over 22 joints among bilateral wrist and finger joints, and the 22-joint (22j)-GS and 22-joint (22j)-PD scores were evaluated as an indicator of US activity using the sum of the GS and PD scores, respectively.The top 6 most affected joints included the bilateral wrist and second/third metacarpophalangeal joints. Therefore, 6-joint (6j)-GS and -PD scores were defined as the sum of the GS and PD scores from the 6 synovial sites over the aforementioned 6 joints, respectively. Although the 22j- or 6j-US scores were significantly correlated with DAS28-ESR or -CRP scores, the correlations were weak. Conversely, 6j-US scores were significantly and strongly correlated with 22j-US scores not only at baseline but also after therapy initiation.Using a multicenter cohort data, our results indicated that a simplified US scoring system could be adequately tolerated during any disease course among patients with RA receiving biological/targeted synthetic DMARDs. 相似文献
90.
Atsushi Yoshimura Mitsuru Kimura Sachio Matsushita Jun-ichi Yoneda Hitoshi Maesato Yasunobu Komoto Hideki Nakayama Hiroshi Sakuma Yosuke Yumoto Tsuyoshi Takimura Tomomi Tohyama Chie Iwahara Takeshi Mizukami Akira Yokoyama Susumu Higuchi 《Alcoholism, clinical and experimental research》2021,45(11):2335-2346